Liver Flashcards
NAFLD risk factors
T2DM, Metabolic syndrome, BMI >30, age, sedentary lifestyle
PCOS, OSA, hypothyroid, NSAIDs, tamoxifen, steroids, amiodarone
NAFLD
Excess triglycerides accumulate in liver causing steatosis often asymptomatic until late stages. Alcohol consumption of over 25ml ethanol daily excludes
Causes of cirrhosis
Alcoholic liver disease - alcohol Hx NAFLD - DM, obesity, HTN Hep B/C - IVDU, transfusions, immigrants Wilsons, Haemochromatosis - FHx Drugs - paracetamol, methotrexate, steriods AI conditions - PBC, PSC, AIH
PC chronic liver disease
malaise, wt loss, lethargy jaundice, oedema, puritis, encephalopathy, ascites abnormal LFTs, hepatosplenomegaly, ? SOB/empysema - a1antitrypsin bloody diarrhoea - PSC
Pathophysiology of liver failure
Steatosis - accumulation of fat in hepatocytes, altered fat metabolism leads to increased liver size
Steatohepatitis - accelerated by alcohol, HBV,HVC, obesity early fibrosis, disrupted architecture and angiogenesis
Cirrhosis - hyperplastic nodules, stellate cells prevent exchange, mass fibrotic tissue leads to impairment of function. Portal HTN, varices
Imaging in hepatology
USS - detect liver lesions and metastasis, dilated bile ducts and gallstones. Quick and non invasive. Can be used to guide biopsy and doppler to assess blood flow
CT - higher sensitivity shows focal liver lesions, contrast for vasculature
MRI - good for biliary tree imagine. MRCP is gold standard. No radiation but pt has to be well and able to lie still in claustrophobic environment for 30 mins
Indications for biopsy
chronic liver disease staging
post transplant rejection
Non invasive liver disease staging
AST:ALT > 0.8 indicative of advanced fibrosis
transient elastography
FIB-4 score
Fibrosis
Extravasation of blood components leads to haemostasis, vasodilation and increased permeability allow immune mediators to enter tissues clotting factors cleave fibrinogen to fibrin forming platelet plug. Active innate and fibroblast activation cause mass inflammation and cell recruitment. Matrix deposition, SM and collagen synthesis = repair. Repeated insults or failure to remove the irritant lead to fibrosis. This disrupts normal tissue architecture and impairs function
Primary biliary cholangitis
AI disease 40-60y/o women. Chronic progressive cholestatic liver disease
Destruction of small and medium intra hepatic ducts leading to disrupted bile flow. Bile irritates hepatic tissue leading to further inflammation and damage
PC PBC
asymptomatic
fatigue, itching due to bile salts
xanthomas - due to increased blood cholesterol
Coexisting AI conditions - Sjorgrens, arthropathy
Advanced liver disease
Inv PBC
AMA +ve, high IgM
increased ALP and GGT
USS to exclude reversible causes of binary obstruction
biopsy granulomatous deposits of inflammation around bile ducts
Complications and Mx PBC
Osteoporosis, hypercholestrolemia, HCC
Monitor yearly USS for HCC and osteoporosis
UDCA - ursodeoxycholic acid hydrophilic synthetic bile acid that improve cholestasis and LFT’s, reduces cholesterol uptake from gut to liver
Fibrates - reduce hypercholestrolemia, cholestryamine - reduce itch
AIH
Continual hepatocellular inflammation and necrosis. Genetic links with HLAD8, DR3. Environmental triggers ; Hep a,b,c, statins and nitrofurantoin
PC AIH
non specific fever, malaise, anorexia, arthralgia
1/3rd present with acute hepatitis - RUQ, fever
Acute liver failure
Links to other AI conditions - Graves, pernicious anaemia, Hashimotos, Sjogrens
Types of AIH
type 1 - 75% all ages ANA and AMSA +ve
type 2 - 15% 10:1 female to male ratio, presents in young adults, LKM1 +ve
Inv AIH
ANA, ASMA +ve
IgG, high ALT due to hepatocyte damage
biopsy shows widespread lymphocytic infiltrate
Mx AIH
Steroids + azathioprine to induce remission
Primary sclerosing cholangitis
Chronic condition that can progress to cirrhosis. Inflammation and fibrosis of the intra and extra hepatic ducts
90% of pt will suffer from IBD
PC PSC
fatigue, jaundice, puritis
can present acutely as ascending cholangitis
progressive leading to chronic liver disease
Inv PSC
pANCA +ve, high ALP
MRCP shows beading of bile ducts and annular strictures
biopsy - onion skin fibrosis. T cell mediated destruction leading to concentric rings of fibrosis.
Complications and Mx of PSC
increased risk of CRC and cholangiocarcinoma
replacement of fat soluble vitamins ADEK
stenting for strictures to prevent cholangitis
regular screening
Acute liver failure
PT increase 4-6 seconds ( INR >1.5)
hepatic enchalopathy
without pre-existing cirrhosis
Causes of acute liver failure
hepatitis A,E,B drugs - paracetamol, isoniazid, halothane, tetracycline, anti epileptics, statins, aspirin Acute fatty liver of pregnancy excess alcohol budd chiari AI hepatitis
Stages of acute liver failure
hyper acute (0-7days) = early renal failure, not often ascites prolonged PT, low bilirubin. high risk of cerebral oedema
acute (8-28) = rare renal failure or ascites, marked coagulopathy
subacute = poor prognosis, cerebral oedema and prolonged PT rare. high bilirubin and risk of ascites
Paracetamol OD
widespread hepatocellular necrosis beginning centrally and spreading towards ports hepatis. Paracetamol metabolised via CYP450 to NAPQI. NAPQI is toxic and requires glutathione to break it down, in overdose glutathione is depleted.
Mx paracetamol OD
N-acetyl cystine @ presentation if paracetamol levels >100g/l
Pt @ high risk are those who are malnourished, and on enzyme inducing drugs
PC acute liver failure
jaundice, RUQ pain, ascites,
encephalopathy - asterixsis, apraxia
N/V, anorexia and malaise
Inv acute liver failure
increased PT, INR
high bilirubin, ALT often in 1000/s
?acidosis
paracetamol levels, U+e’s, ABG, ferritin, hep serology, AIH markers
MRI allows calculation of liver volume if below 1000ml = poor prognosis
Complications of acute liver failure
Coagulopathy - necrosis leads to inadequate synthesis of coagulation factors. progressive thrombocytopenia = increased risk of DIC or cerebral bleed
Renal failure - ATN or due to hyperdynamic circulation leading to hepatorenal syndrome
Infection risk - mass systemic inflammatory response leading to organ failure, reduce leukocyte function
Cardiac - high output state with peripheral vasodilation leads to hypotension, increased CO and adrenal insufficiency lead to reduced PR - ARDS/ pul oedema
Hypoglycaemia and hyperammonia
Pathogenesis of hepatic encephalopathy
cerebral vasomotor dysfunction leads to vasodilation of cerebral blood vessels to increase blood flow. SIRS = increased capillary permeability - cerebral oedema. Astrocytes swell converting excess ammonia to glutamine. Glutamine = osmotic effect drawing h20 into cells
PC encephalopathy
Personality changes, reduced GCS, asterixis, increased ICP - papilloedema, vomiting.
Grade I GCS 14-15 slurred speech, inverted sleep wake
Grade II = 11-13 drowsiness, confusion
Grade 3 = 8-11 somnolence, inability to perform tasks
Grade IV < 8 coma
Mx of increased ICP
20% mannitol, target Na+ <150, hypothermia, burr hole if due to bleed.
Urgent transplant for acute liver failure
i) Paracetamol = pH < 7.25 or all of the following PT >100, lactate >3.5, HE grade III/ IV
ii) Non paracetamol = PT >100 or 3/5 drug induced, 40+, jaundice 1 wk prior, bilirubin >300, PT >50
Mx acute liver failure
ITU - NAC stat for paracetamol OD, withdraw hepatic drugs . Glucose and vit K
prophylactic anti fungal and ABx
steroids for AIH
Causes of hepatic encephalopathy
GI bleed, renal failure, acute liver injury
diuretic use
constipation
infections
Mx hepatic encephalopathy
protect airway, treat underlying
lactulose to reduce generation of NH3 by gut bacteria by reducing gut transit time
HCC monitoring
@ risk pt get 6 monthly USS and aFP monitoring. These include hep B,C, alcoholic with cirrhosis, AI - PSC, haemochromatosis.
CT scans and HCC
Contrast used to identify tumor, should glow white on injection due to vascularisation and show venous washout due to extensive venous network
Prevention of HCC
1 - vaccinate HBV avoid alcohol
2 - venesect haemochromatosis pt, lose wt/control DM for NAFLD, abstain from alcohol cirrhotics
PC HCC
Hard to distinguish from CLD hence why screening is used.
wt loss, malaise, RUQ pain moving to back
jaundice - early in cholangiocarcioma
hepatomegaly +/- bruit
Childs Pugh
Used to assess grade of cirrhosis and risk of vatical bleed
Mx HCC
Dependent on scoring
A - carcinoma in situ, normal portal pressures resection
B-C early stages 3 nodules max possible transplant
D - palliative care